Investigating COVID-19 Vaccination Patterns in Europe-Reference-Cited by-同舟云学术

Investigating COVID-19 Vaccination Patterns in Europe

Published:2023-02-20 Issue: Volume: Page:219-246
ISSN:2327-9354
Container-title:Advances in Medical Technologies and Clinical Practice
language:
Short-container-title:

Author:

Adusei-Mensah Frank¹^ORCID,Inkum Ivy E.²,Oduro Kennedy J.³

Affiliation:

1. University of Eastern Finland, Finland

2. Mantyla Kotihoito, Finland

3. Cape Coast Teaching Hospital, Ghana

Abstract

The present chapter aims to investigate the occurrence of COVID-19 vaccine administration patterns in Europe for effective vaccination and booster shot scheduling towards COVID-19 pandemic control. Method: Data were obtained from the ECDC on COVID-19 vaccination radar on 5th March 2021 and processed for statistical analysis with IBM's SPSS version 21. Statistically, a significant difference was considered at p less than 0.05. Results: The authors observed statistically significant lower vaccine uptake compared to delivered doses (average at 62.678 ± 3.928%). Uptake for Oxford-AstraZeneca vaccines (50.927 ± 4.626%) compared to Pfizer-Biontech vaccine (86.285 +/- 2.1052%) was observed compared to previous prospective study on the wiliness to receive COVID-19 vaccine in the region (75%). Conclusion: The early COVID-19 acceptance pattern based on vaccine type or manufacturer was observed. The findings will be useful for policymakers to introduce policies on educational campaigns to enhance vaccine and booster uptake for smooth and effective control of the pandemic.

Publisher

IGI Global

Reference51 articles.

1. Sauramäki, J. M., Adusei-Mensah, F., Hakalehto, J., Armon, R., & Hakalehto, E. (2022). 7 Pandemic situation and safe transportation, storage, and distribution for food catering and deliveries. In E. Hakalehto (Ed.), Microbiology of Food Quality: Challenges in Food Production and Distribution During and After the Pandemics (pp. 149–172). De Gruyter. .

2. Randomised controlled trials for Ebola: Practical and ethical issues.;C.Adebamowo;Lancet,2014

3. Adusei-Mensah, F., Hakalehto, E., & Tikkanen-Kaukanen, C. (2021). Microbiological and Chemical Safety of African Herbal and Natural Products. In E. Hakalehto (ed.) Challenges in Food Production and Distribution During and After the Pandemic. Degruyter.

4. Adusei-Mensah, F., Kauhanen, J., & Tikkanen-Kaukanen, C. (2022). The Need for a Paradigm Shift in the Existing Strategies for Effective COVID-19 Control. Online Journal of Contemporary Medicine.

5. AstraZeneca. (2021). A Phase III Randomized, Double-blind, Placebo-controlled Multicenter Study in Adults, to Determine the Safety, Efficacy, and Immunogenicity of AZD1222, a Non-replicating ChAdOx1 Vector Vaccine, for the Prevention of COVID-19 (Clinical Trial Registration No. NCT04516746). clinicaltrials.gov. https://clinicaltrials.gov/ct2/show/NCT04516746